Olmesartan Medoxomil clinical trials
Also written Benicar and Olmetec.
A product of Olmesartan; its studies count on that page too.
How each study uses Olmesartan Medoxomil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Olmesartan Medoxomil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Apr 2002 · BENICAR · NDA 021286 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2005 (10)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 10 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 37 · Other 9
Daiichi Sankyo (20) · Sankyo Pharma Gmbh (7) · Mylan Pharmaceuticals Inc (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · Daiichi Sankyo Co., Ltd. (2) · EMS (2) · Pharmtechnology LLC (1) · Virginia Polytechnic Institute and State University (1)
Often tested with
Tested in the same studies.
Amlodipine (10) · Hydrochlorothiazide (9) · Losartan (4) · Irbesartan (2) · Valsartan (2) · Telmisartan (2) · OLM 40MG (1) · Probenecid (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Olmesartan
- One of Angiotensin II Type 1 Receptor Blockers source
- One of Angiotensin receptor blockers (ARBs) source
Studies
Open first, then newest update. How each study uses Olmesartan Medoxomil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 46
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as BenicarHow we know
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnPhase 3EMSNCT02493322Written as Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mgHow we know
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnPhase 3EMSNCT02483936Written as Olmesartan medoxomil 40mg + chlorthalidone 12,5mgHow we know
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649623Written as Olmesartan Medoxomil Tablets 40 mgHow we know
- Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648219Written as Olmesartan Medoxomil Tablets 40 mgHow we know
- A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established AtherosclerosisCompletedPhase 3Daiichi SankyoNCT00382213Written as Olmesartan medoxomilHow we know
- The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.CompletedPhase 1Pharmtechnology LLCNCT03951051Written as Olmesartan Medoxomil 40 mgHow we know
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedPhase 3Daiichi SankyoNCT00902538Written as Olmesartan medoxomil 40 mg - Amlodipine 10 mgHow we know
- Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedPhase 3Daiichi SankyoNCT00923091Written as olmesartan medoxomil + amlodipineHow we know
- Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCompletedPhase 3Daiichi SankyoNCT00649389Written as Olmesartan medoxomilHow we know
- A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedPhase 4Daiichi SankyoNCT00791258Written as amlodipine and olmesartan medoxomil tabletsHow we know
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedPhase 3Daiichi SankyoNCT00430508Written as olmesartan medoxomil/hydrochlorothiazide tabletsHow we know
- Amlodipine as add-on to Olmesartan in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220220Written as olmesartan medoxomilHow we know
- Olmesartan as an add-on to Amlodipine in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220233Written as olmesartan medoxomilHow we know
- Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCompletedPhase 3Daiichi SankyoNCT00185133Written as Olmesartan medoxomilHow we know
- Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedPhase 3Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT00676845Written as olmesartan medoxomilHow we know
- The Confirmatory Olmesartan Plaque Regression StudyTerminatedPhase 4Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT01132768Written as olmesartan medoxomilHow we know
- Angiotensin II Blockade and Inflammation in ObesityCompletedPhase 4Virginia Polytechnic Institute and State UniversityNCT01684748Written as Olmesartan medoxomilHow we know
- Lowering Blood Pressure in Primary Care in ViennaCompletedPhase 4Wilhelminenspital ViennaNCT02377661Written as Olmesartan medoxomil, amlodipine, hydrochlorothiazideHow we know
- An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesCompletedPhase 4Daiichi SankyoNCT00403481Written as olmesartan medoxomilHow we know
See all 46 studies that test Olmesartan Medoxomil →
Given beside what is tested · 3 — Olmesartan Medoxomil is usual care or a partner of the new treatment
- Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionCompletedPhase 3NovartisNCT00523744Written as Olmesartan medoxomilHow we know
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Olmesartan medoxomilHow we know
- A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy VolunteersStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT02561884Written as Co-administration of Olmetec and CrestorHow we know
As the comparator · 8 — what is tested is compared with Olmesartan Medoxomil
- Study of CS-3150 Compared to Olmesartan in Patients With Essential HypertensionCompletedNot applicableDaiichi Sankyo Co., Ltd.NCT02848170Written as olmesartan medoxomilHow we know
- Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedPhase 3Lee's Pharmaceutical LimitedNCT02609490Written as Olmesartan medoxomil tabletsHow we know
- Fimasartan Achieving SBP Target (FAST) StudyCompletedPhase 4Boryung Pharmaceutical Co., LtdNCT02495324Written as Olmesartan medoxomilHow we know
- Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT02407210Written as Olmesartan medoxomilHow we know
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedPhase 3TakedaNCT01309828Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00996281Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
- A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276CompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01493856Written as OlmetecHow we know
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedPhase 3TakedaNCT01033071Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
Codes
What other systems call Olmesartan Medoxomil · ClinicalTrials.gg INT006516
- MeSH (NLM) D000068557Olmesartan MedoxomilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6M97XTV3HDOLMESARTAN MEDOXOMILConfirmed FDA, NLM, Wikidata
- RxNorm 118463Confirmed FDA, Wikidata
- Wikidata Q27888058olmesartan medoxomilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47640Olmesartan MedoxomilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068557 | Olmesartan Medoxomil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6M97XTV3HD | OLMESARTAN MEDOXOMIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 118463 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27888058 | olmesartan medoxomil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47640 | Olmesartan Medoxomil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.